Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

1.3K
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.3K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

434
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
434
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

822
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
822
Anatomy of the Genitourinary System II: Bladder and Urethra01:19

Anatomy of the Genitourinary System II: Bladder and Urethra

3.6K
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
3.6K
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

53
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[bobotulinum toxin A (Dysport) for the treatment of neurogenic detrusor overactivity].

Urologiia (Moscow, Russia : 1999)·2023
Same author

[Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians].

Terapevticheskii arkhiv·2022
Same author

Primary myxoid leiomyosarcoma of renal pelvis: Case report and literature review.

Urology case reports·2022
Same author

[Pharmacokinetic features of sildenafil spray in healthy men depending on food intake].

Urologiia (Moscow, Russia : 1999)·2020
Same author

[Socio-economic aspects of neurogenic dysfunctions in urology].

Urologiia (Moscow, Russia : 1999)·2020

Related Experiment Video

Updated: Apr 30, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K

[Lower urinary tract symptoms in men].

G G Krivoborodov

    Urologiia (Moscow, Russia : 1999)
    |April 30, 2014
    PubMed
    Summary

    Lower urinary tract symptoms (LUTS) in men are common. Treatment for benign prostatic hyperplasia (BPH) focuses on symptom severity, using alpha-adrenoblockers for obstructive LUTS and combination therapy for progressive BPH.

    Area of Science:

    • Urology
    • Geriatrics
    • Pharmacology

    Context:

    • Lower urinary tract symptoms (LUTS) are prevalent, particularly in aging male populations.
    • Benign prostatic hyperplasia (BPH) is a common cause of LUTS in men.
    • Accurate assessment of LUTS severity using tools like the International Prostate Symptom Score (IPSS) is crucial for guiding treatment decisions.

    Purpose:

    • To outline primary treatment strategies for men experiencing LUTS, with a focus on BPH management.
    • To emphasize the importance of identifying predominant symptoms to tailor therapeutic interventions.
    • To guide the selection of pharmacotherapy based on symptom presentation and disease progression.

    Summary:

    • Drug treatment is recommended for BPH in the absence of surgical indications.

    More Related Videos

    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.7K
    Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
    10:23

    Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

    Published on: December 1, 2017

    16.6K

    Related Experiment Videos

    Last Updated: Apr 30, 2026

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
    05:25

    Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

    Published on: August 14, 2019

    19.7K
    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.7K
    Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice
    10:23

    Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice

    Published on: December 1, 2017

    16.6K
  • Alpha-adrenoblockers are the first-line therapy for obstructive LUTS.
  • Combination therapy with 5-alpha-reductase inhibitors is indicated for progressive BPH (prostate volume ≥ 40 cm³, PSA > 1.5 ng/mL).
  • For irritative LUTS in BPH patients, combined alpha-adrenoblockers and M-cholinergic antagonists are effective.

    • Impact:

    • Provides a clear treatment algorithm for LUTS secondary to BPH.
    • Facilitates evidence-based pharmacotherapy selection for urologists and primary care physicians.
    • Aims to improve patient outcomes by optimizing treatment based on symptom profiles and disease severity.